Skip to content

Are longevity clinics worth the cost for lifespan extension?

Reviewed by CureMed LabsUpdated
A physician and a patient reviewing lab results and biomarker charts on a laptop in a modern longevity clinic consultation room
The consultation is where a clinic's evidence either gets applied to you specifically or stays on a slide.
Simply put

Longevity clinics are worth their cost for lifespan only if the money buys the things proven to help you live longer — controlling blood pressure and cholesterol particles, quitting smoking, weight-loss drugs where indicated, and structured coaching that makes those happen — with a doctor you see often. Those things are cheap and available through ordinary care. The expensive parts of a membership — whole-body MRI, biological-age tests, peptides — have no evidence for lifespan. A physician-led programme with frequent contact can be worth a moderate premium; a concierge membership as sold is not; scan-led and hormone clinics never are.

The short answer

For lifespan extension specifically, a longevity clinic is worth its cost only to the extent the fee buys the components with mortality evidence — blood-pressure and ApoB control, smoking cessation, GLP-1 agonists in the right patients, and structured coaching that makes those happen — and ranked by tier on that basis: a physician-led programme that delivers those with frequent contact is worth a moderate premium, because sustained structured contact is what the prevention trials showed works; a blood-panel subscription at $199–$365 is worth it as a cheap way to track ApoB and HbA1c if a physician acts on them; a concierge membership at $7,500–$19,000 is not worth it for lifespan as sold, because most of the fee buys whole-body MRI, epigenetic age and novelty tests with no mortality evidence, at a cadence of one annual review; scan-led and hormone-led clinics are not worth it for lifespan at any price. The components that extend life are available through primary care for a fraction of the cost; what a clinic can add is time, structure and follow-through — and that is the only thing worth paying for. No clinic has shown, and none could yet show, that its membership extends life.

  • The parts of a membership with mortality evidence are the cheap, generic parts; the parts that set the price have none.
  • Cochrane found no mortality benefit from the general health check as a bundle in 17 trials — the components work, the annual event does not.
  • Structured, frequent contact is the one thing a clinic can add that the trials support; a single annual review is not that.
  • No clinic has a trial showing its membership extends life; claims of 'reversed biological age' rest on tests that vary with lunch.
  • The same lifespan evidence costs a few hundred a year through a physician; the premium buys imaging.
'Worth it for lifespan' is answerable, because the components of a longevity membership have been tested for mortality separately: some reduce deaths in randomised trials, most have never been tested, and the bundle itself — the annual health check — was tested in 17 trials and did not. The question therefore comes down to what share of a clinic's fee buys the first kind of component, and at what cadence.
This guide gives a pharmacist's verdict tier by tier, drawing on the site's longevity-clinics section for the published prices and cadences and its evidence ledger for what has mortality data. It is direct about the one thing a clinic can genuinely add toward a longer life and honest that no clinic has shown, or could yet show, that its membership extends it.

Worth it for lifespan, tier by tier

Ranked on: the share of the fee that buys components with randomised mortality evidence, the cadence at which they are delivered, and the price of obtaining the same components through primary care. Components without mortality evidence count as cost, not value.

Verdict at a glance
#OptionVerdictGrade
1Physician-led programme with frequent contact, imaging declinedWorth a moderate premium — for the contact, not the testsGRADE AEstablished
2Your own physician running the evidence-based scheduleWorth it, and nearly freeGRADE AEstablished
3Blood-panel subscriptionWorth $199–$365 as a tracking tool, if a physician acts on itGRADE BPromising
4Concierge diagnostic membership as soldNot worth it for lifespan; most of the fee buys tests without mortality evidenceGRADE CEarly
5Scan-led membershipNot worth it for lifespan at any priceGRADE DInsufficient or unsafe
6Hormone-optimisation and peptide clinicNot worth it; some offerings carry harmGRADE DInsufficient or unsafe
  1. 01

    Physician-led programme with frequent contact, imaging declined

    GRADE AEstablishedWorth a moderate premium — for the contact, not the tests

    Blood pressure and ApoB to target, smoking cessation, GLP-1 agonists where indicated and structured coaching are the components with mortality or hard-outcome evidence, and sustained structured contact is what US POINTER and the diabetes-prevention trials showed converts them into results. A programme that delivers those quarterly, with a medication review, buys the one thing primary care struggles to provide. Worth it if the cadence is in writing and the MRI is out.

  2. 02

    Your own physician running the evidence-based schedule

    GRADE AEstablishedWorth it, and nearly free

    The same mortality-evidenced components — antihypertensives, ApoB-lowering therapy, cessation support, GLP-1 prescribing, guideline screening — through primary care, mostly covered. Lacks the coaching intensity and the coordination; contains every lifespan lever a clinic sells. The benchmark any fee must beat.

  3. 03

    Blood-panel subscription

    GRADE BPromisingWorth $199–$365 as a tracking tool, if a physician acts on it

    Tracks ApoB, HbA1c, ferritin and the rest cheaply over years; contains no intervention, no coaching and no screening. Worth it for lifespan only as the measurement half of a plan someone else executes. On its own it extends a dashboard, not a life.

  4. 04

    Concierge diagnostic membership as sold

    GRADE CEarlyNot worth it for lifespan; most of the fee buys tests without mortality evidence

    Of $7,500–$19,000 a year, the components with lifespan evidence are a small fraction; whole-body MRI, epigenetic age, CGM in non-diabetics and multi-analyte novelty are the differentiators and have none. At published cadences of one physician review a year, the structured contact that would justify a premium is absent. Becomes worth it only when renegotiated into the first tier.

  5. 05

    Scan-led membership

    GRADE DInsufficient or unsafeNot worth it for lifespan at any price

    A whole-body MRI has no mortality evidence, a finding rate of a third with documented cascade harm, and no lifespan lever attached to it. £299 or $4,999, the lifespan value is the same: none.

  6. 06

    Hormone-optimisation and peptide clinic

    GRADE DInsufficient or unsafeNot worth it; some offerings carry harm

    Testosterone without deficiency, growth-hormone secretagogues, compounded peptides and hGH for anti-ageing have no lifespan evidence and quantified or documented harms. The fee buys risk.

The arithmetic of a membership

What in a longevity membership has lifespan evidence, and what it costs elsewhere

ComponentMortality or hard-outcome evidenceTypical share of a concierge feeCost through primary care
Blood-pressure control to targetSPRINT: fewer deathsSmallCovered; generic drugs
ApoB-lowering therapy26-trial meta-analysis: lower mortalitySmallCovered; generic statins; ApoB test on request
Smoking cessationTen years of life expectancyNegligible — rarely on the menuFree
GLP-1 agonist where indicatedSELECT: fewer CV events in that populationSmallPrescribable; drug cost varies
Structured coaching, frequent contactUS POINTER, DPP: outcome benefitModerate — where it existsHard to get; the genuine gap
Guideline cancer screeningRandomised mortality reductionSmall, when includedCovered; the programme recalls you
VO₂max, DEXAStrong prediction; training changes themModerateA sports-medicine lab
Whole-body MRINone; harm signalsLargeNot recommended
Epigenetic age, CGM, omicsNoneLargeNot recommended
Compounded peptides, IV therapyNone; harm signalsVariableNot recommended
The rows with evidence are cheap everywhere. The rows without evidence are what the membership fee is for.

Frequently asked questions

Are longevity clinics worth the cost for lifespan extension?

Only to the extent the fee buys the components with mortality evidence — blood-pressure and ApoB control, smoking cessation, GLP-1 agonists where indicated, structured coaching — delivered with frequent contact. A physician-led programme that does that is worth a moderate premium; a blood-panel subscription is worth $199–$365 as a tracking tool; a concierge membership as sold is not worth $7,500–$19,000 for lifespan, because most of the fee buys imaging and omics with no mortality evidence at one annual review; scan-led and hormone clinics are not worth it at any price.

Has any longevity clinic shown it extends life?

No, and none could yet: a trial of a membership against usual care with a mortality endpoint would take decades and has not been run. Claims of reversed biological age rest on epigenetic clocks that vary with a meal and have no clinical-validity requirement. The components inside a membership have separate mortality evidence; the membership itself has none.

What in a longevity membership actually has lifespan evidence?

Blood-pressure control to target (fewer deaths in SPRINT), ApoB-lowering therapy (lower mortality across 26 trials), smoking cessation (about ten years of life expectancy), GLP-1 agonists in people with obesity and cardiovascular disease (fewer events in SELECT), structured lifestyle coaching (outcome benefit in US POINTER and the diabetes-prevention trials) and guideline cancer screening. All are cheap or covered through primary care.

Why did Cochrane find health checks do not reduce mortality?

Because bundling every test into an annual event offered to everyone does not add to the benefit of the components — treating blood pressure and lipids — which have their own strong evidence. Across 17 randomised trials and 251,891 adults, total mortality was unchanged with high certainty. A longevity membership is that bundle with a scanner; its lifespan value is in delivering the evidence-based components more consistently, not in the menu.

Is a concierge membership ever worth it for lifespan?

When renegotiated: whole-body imaging and novelty tests declined, quarterly physician contact and a coaching layer put in writing, a medication review included. At that point most of what remains has evidence and the premium buys time and structure. As sold — one annual review, an MRI, an epigenetic age — the fee buys tests without mortality evidence.

What is the cheapest way to get the lifespan benefit clinics sell?

A primary-care physician who runs the evidence-based panel — ask for ApoB and Lp(a) by name — treats blood pressure and ApoB to target, supports cessation, prescribes a GLP-1 agonist where indicated and coordinates guideline screening; a coach or physiotherapist for the training; a pharmacist for the medication review. It costs a few hundred a year or less and contains every lifespan lever a clinic offers, lacking only the coordination.

Keep reading

More in Longevity clinics

  • What are the best longevity clinics for anti-aging?

    Longevity clinic models ranked for anti-ageing on published evidence, physician contact and price: academic and hospital-based prevention clinics, physician-led longitudinal programmes, blood-panel subscriptions (Function Health, Superpower), concierge diagnostics (Human Longevity, Biograph), scan-led memberships (Neko, Prenuvo), hormone and peptide clinics — with a pharmacist's verdict on which model is worth joining.

  • How to choose the best longevity clinic for me?

    A ranked method for matching a longevity clinic to your situation: what you already have, what you actually need, what you will use, and what you can pay — with the clinic model that fits each profile, from a well person with a good GP to a high-risk patient with no primary care.

  • Which longevity clinic offers the most comprehensive health optimization?

    Longevity clinic models ranked on genuine comprehensiveness — coverage of the levers with outcome evidence (cardiovascular, metabolic, fitness, strength, sleep, smoking, screening, medication) rather than number of tests: physician-led programmes, academic clinics, blood-panel subscriptions, concierge memberships, scan-led clinics.

  • What tests do top longevity clinics typically include?

    The tests top longevity clinics include, ranked by evidence: standard and advanced blood work (ApoB, Lp(a), insulin, hs-CRP), coronary calcium and CT angiography, DEXA and VO₂max, guideline cancer screening, whole-body MRI, epigenetic clocks, CGM, genomics, microbiome, multi-cancer blood tests — with what each clinic tier includes and what primary care already covers.

  • How to compare different longevity clinics and programs?

    Eight criteria for comparing longevity clinics and programmes, ranked by how much they separate a good clinic from an expensive one: physician contact, evidence share of the menu, follow-through, credentials, cascade management, total cost, conflicts of interest, published limits — with a scoring sheet.

  • What results can I expect from a longevity clinic?

    The results a longevity clinic can realistically deliver, ranked by likelihood and evidence: blood pressure and ApoB at target, HbA1c and weight, VO₂max and strength, sleep, a cleaned-up medication list, screening on schedule — and the results it cannot deliver: reversed biological age, extended lifespan, a clean whole-body scan.

Reader reviews

No reviews yet — be the first.
Write a review

Every review is read by our team before it publishes. We remove nothing for being negative — only for being fake, off-topic or abusive.

The Longevity Brief

One evidence-graded email a week: what is new in longevity research, what is hype, and the one change actually worth making.

Free · one email a week · unsubscribe anytime.